RE 19 (Atenolol 25 mg)
Pill with imprint RE 19 is White, Round and has been identified as Atenolol 25 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Atenolol is used in the treatment of anxiety; alcohol withdrawal; angina pectoris prophylaxis; angina; esophageal variceal hemorrhage prophylaxis and belongs to the drug class cardioselective beta blockers. There is positive evidence of human fetal risk during pregnancy. Atenolol 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RE 19
Atenolol
- Imprint
- RE 19
- Strength
- 25 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- Inactive Ingredients
-
magnesium carbonate,
magnesium stearate,
silicon dioxide,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
corn starch
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 63304-0621 | Ranbaxy Pharmaceuticals Inc. |
| 53002-1108 | Pharmedix (repackager) |
Related images for "RE 19"
More about atenolol
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (248)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: cardioselective beta blockers
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.